Insight Molecular Diagnostics Inc. Q2 FY2024 Earnings Call

Insight Molecular Diagnostics Inc. (IMDX)

Earnings Call FY2024 Q2 Call date: 2024-08-08 Concluded

Quarter scorecard

Revenue

$104,000

-77.5% YoY

Diluted EPS

$-0.36

Gross margin

48.1%

-10.6 pp YoY

Net income

-$4.53M

Laboratory Services $104,000

Kitted Products $0

Laboratory Developed Test Services $0